IL135621A0 - Anti-estrogen plus progestin containing oral contraceptives - Google Patents

Anti-estrogen plus progestin containing oral contraceptives

Info

Publication number
IL135621A0
IL135621A0 IL13562198A IL13562198A IL135621A0 IL 135621 A0 IL135621 A0 IL 135621A0 IL 13562198 A IL13562198 A IL 13562198A IL 13562198 A IL13562198 A IL 13562198A IL 135621 A0 IL135621 A0 IL 135621A0
Authority
IL
Israel
Prior art keywords
oral contraceptives
containing oral
estrogen plus
plus progestin
progestin containing
Prior art date
Application number
IL13562198A
Other languages
English (en)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of IL135621A0 publication Critical patent/IL135621A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13562198A 1997-11-06 1998-11-04 Anti-estrogen plus progestin containing oral contraceptives IL135621A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96508397A 1997-11-06 1997-11-06
PCT/US1998/023427 WO1999024027A2 (en) 1997-11-06 1998-11-04 Anti-estrogen plus progestin containing oral contraceptives

Publications (1)

Publication Number Publication Date
IL135621A0 true IL135621A0 (en) 2001-05-20

Family

ID=25509417

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13562198A IL135621A0 (en) 1997-11-06 1998-11-04 Anti-estrogen plus progestin containing oral contraceptives

Country Status (28)

Country Link
EP (1) EP1051179B1 (ja)
JP (1) JP2001522798A (ja)
CN (1) CN1278732A (ja)
AR (1) AR016667A1 (ja)
AT (1) ATE304359T1 (ja)
AU (2) AU760540B2 (ja)
BG (1) BG104451A (ja)
BR (1) BR9813982A (ja)
CA (1) CA2307210A1 (ja)
CZ (1) CZ294155B6 (ja)
DE (1) DE69831605T2 (ja)
DK (1) DK1051179T3 (ja)
EA (1) EA200000492A1 (ja)
EE (1) EE04092B1 (ja)
ES (1) ES2246541T3 (ja)
GE (1) GEP20043290B (ja)
HR (1) HRP20000269A2 (ja)
HU (1) HUP0100293A3 (ja)
ID (1) ID24568A (ja)
IL (1) IL135621A0 (ja)
NO (1) NO20002167L (ja)
NZ (1) NZ503890A (ja)
PL (1) PL340623A1 (ja)
SK (1) SK6482000A3 (ja)
TR (1) TR200001268T2 (ja)
UA (1) UA68365C2 (ja)
WO (1) WO1999024027A2 (ja)
ZA (1) ZA9810136B (ja)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120263A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to prevent bone loss-progesterone and estrogen agonists
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
SK284666B6 (sk) * 1998-05-15 2005-08-04 Wyeth Farmaceutický prostriedok obsahujúci indolové zlúčeniny a estrogény a jeho použitie
US6380166B1 (en) 1999-09-13 2002-04-30 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
TWI287018B (en) * 1999-09-13 2007-09-21 Wyeth Corp Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
CA2448235A1 (en) 2001-07-31 2003-02-13 Pfizer Products Inc. Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
PT1809602E (pt) 2004-10-27 2008-12-15 Janssen Pharmaceutica Nv Derivados de indole úteis como moduladores do receptor da progesterona
FR2880625B1 (fr) * 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
UY29527A1 (es) 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
DE102008057230A1 (de) * 2008-11-11 2010-05-12 Bayer Schering Pharma Aktiengesellschaft Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin
KR101698238B1 (ko) 2010-06-10 2017-01-19 세라곤 파마슈티컬스, 인크. 에스트로겐 수용체 조정제 및 이의 용도
SG11201403002RA (en) 2011-12-14 2014-07-30 Seragon Pharmaceuticals Inc Fluorinated estrogen receptor modulators and uses thereof
BR122023020677A2 (pt) 2015-10-01 2023-12-12 Olema Pharmaceuticals, Inc. Compostos de tetra-hidro-1h-pirido[3,4-b]indol, composições compreendendo os referidos compostos e usos dos mesmos
PL3386500T3 (pl) 2015-12-09 2023-03-13 The Board Of Trustees Of The University Of Illinois Selektywne antagonisty receptora estrogenowego na bazie benzotiofenu
CN109562113A (zh) 2016-05-10 2019-04-02 C4医药公司 用于靶蛋白降解的螺环降解决定子体
CN109641874A (zh) 2016-05-10 2019-04-16 C4医药公司 用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
WO2017197055A1 (en) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. Heterocyclic degronimers for target protein degradation
CA3028751A1 (en) 2016-07-01 2018-01-04 G1 Therapeutics, Inc. Pyrimidine-based antiproliferative agents
WO2018081168A2 (en) 2016-10-24 2018-05-03 The Board Of Trustees Of The University Of Illinois Benzothiophene-based selective mixed estrogen receptor downregulators
AR110728A1 (es) 2017-01-06 2019-04-24 G1 Therapeutics Inc Terapia combinada para el tratamiento del cáncer
TW201835064A (zh) 2017-02-10 2018-10-01 美商G1治療公司 苯并噻吩雌激素受體調節劑
AU2018291026B2 (en) 2017-06-29 2022-09-01 G1 Therapeutics, Inc. Morphic forms of GIT38 and methods of manufacture thereof
EP3897631A4 (en) 2018-12-20 2022-11-23 C4 Therapeutics, Inc. TARGETED PROTEIN DEGRADATION
PE20221724A1 (es) 2019-12-20 2022-11-04 C4 Therapeutics Inc Compuestos de isoindolinona e indazol para la degradacion del receptor del factor de crecimiento epidermico (egfr)
WO2021178920A1 (en) 2020-03-05 2021-09-10 C4 Therapeutics, Inc. Compounds for targeted degradation of brd9
WO2024030968A1 (en) 2022-08-03 2024-02-08 Brystol-Myers Squibb Company Compounds for modulating ret protein
WO2024097980A1 (en) 2022-11-04 2024-05-10 Bristol-Myers Squibb Company Ret-ldd protein inhibitors
WO2024097989A1 (en) 2022-11-04 2024-05-10 Bristol-Myers Squibb Company Ret-ldd protein degraders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA716118B (en) * 1970-10-05 1972-05-31 Richardson Merrell Inc Contraception
ZA9510926B (en) * 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
IL120266A (en) * 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
IL120263A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to prevent bone loss-progesterone and estrogen agonists
EP0802183B1 (en) * 1996-04-19 2001-10-10 American Home Products Corporation Estrogenic agents
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive

Also Published As

Publication number Publication date
SK6482000A3 (en) 2000-11-07
AU1303199A (en) 1999-05-31
DK1051179T3 (da) 2005-10-31
CN1278732A (zh) 2001-01-03
EP1051179A2 (en) 2000-11-15
NO20002167L (no) 2000-06-28
UA68365C2 (en) 2004-08-16
GEP20043290B (en) 2004-07-26
HUP0100293A2 (hu) 2001-10-28
ATE304359T1 (de) 2005-09-15
WO1999024027A2 (en) 1999-05-20
ID24568A (id) 2000-07-27
BR9813982A (pt) 2000-09-26
HRP20000269A2 (en) 2000-12-31
BG104451A (en) 2000-12-29
CA2307210A1 (en) 1999-05-20
ES2246541T3 (es) 2006-02-16
EE200000211A (et) 2001-04-16
CZ20001661A3 (cs) 2000-12-13
EP1051179B1 (en) 2005-09-14
AU760540B2 (en) 2003-05-15
NO20002167D0 (no) 2000-04-27
CZ294155B6 (cs) 2004-10-13
PL340623A1 (en) 2001-02-12
TR200001268T2 (tr) 2001-01-22
NZ503890A (en) 2002-08-28
HUP0100293A3 (en) 2002-12-28
JP2001522798A (ja) 2001-11-20
ZA9810136B (en) 2000-05-05
DE69831605T2 (de) 2006-06-14
EE04092B1 (et) 2003-08-15
AR016667A1 (es) 2001-07-25
WO1999024027A3 (en) 1999-07-15
DE69831605D1 (de) 2005-10-20
AU2003204896B2 (en) 2006-06-15
EA200000492A1 (ru) 2000-10-30

Similar Documents

Publication Publication Date Title
IL135621A0 (en) Anti-estrogen plus progestin containing oral contraceptives
AU2003204896A1 (en) Anti-estrogen plus progestin containing oral contraceptives
HK1017854A1 (en) Oral composition
EP1043030A4 (en) MEDICINAL COMPOSITIONS WITH PROLONGED RELEASE
HUP0104680A3 (en) Triphasic oral contraceptive
AU3888597A (en) Oral contraceptive
EP1037814A4 (en) OPEN MOUTH BAG
HUP9904345A3 (en) Oral contraceptive
AU3888697A (en) Progestin/estrogen oral contraceptive
PL322596A1 (en) Antiglucocorticoid drug
AU3961697A (en) Oral contraceptive
IL137541A0 (en) New contraceptive kit
GB2328878B (en) Medico-surgical tubes
AU135502S (en) Condom
GB9716124D0 (en) Condoms
AU2815897A (en) Oral contraceptive
GB9718524D0 (en) Condom advent calendar
GB9720612D0 (en) Medico-surgical tubes
AU2926897A (en) Oral contraceptive
AU2746097A (en) Oral contraceptive
IL120398A0 (en) Low dosage contraceptive
AU133875S (en) Small mouth mask
AU133886S (en) Large mouth mask
EP1148884A4 (en) Contraceptive with graded progestin
TW319068U (en) Improved condom structure